✦ LIBER ✦

A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma

✍ Scribed by David H. Ilson; Matthew Sirott; Leonard Saltz; Robert Heelan; Ying Huang; Roger Keresztes; David P. Kelsen

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 574 KB
Volume: 75
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19950501)75:9<2197::aid-cncr2820750902>3.0.co;2-s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of 5-fluorouracil, leucov

Phase II trial of 5-fluorouracil, leucovorin, interferon-α-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinoma

✍ Barbara K. Temeck; James E. Liebmann; Christopher Theodossiou; Seth M. Steinberg 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

## BACKGROUND. Most patients with esophageal carcinoma present with locally advanced disease and a poor prognosis. Surgery or radiation provides palliation for locally advanced esophageal carcinoma. The role of neoadjuvant therapy remains to be defined. We administered neoadjuvant chemotherapy cons

A phase II trial of alpha-interferon and

A phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors

✍ Leonard Saltz; Nancy Kemeny; Gary Schwartz; David Kelsen 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 400 KB 👁 2 views

5-Fluorouracil/leucovorin/interferon alp

5-Fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer

✍ Peter B. Vermeulen; Luc Y. Dirix; Gino Pelgrims; Allan T. van Oosterom; Nanno H. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB 👁 2 views

A phase I trial of 5-fluorouracil, folin

A phase I trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinoma

✍ Ronald M. Bukowski; Go Inoshita; Prasad Yalavarthi; Siva Murthy; Vicki Gibson; G 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB 👁 2 views

A Phase II trial of 5-fluorouracil and r

A Phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma

✍ Richard Pazdur; Jaffer A. Ajani; Rodger Winn; James Bearden; Robert J. Belt; Sus 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB 👁 3 views

A Phase I1 clinical trial of the combination of 5-fluorouracil (5-FU) and recombinant alpha-2a-interferon (a-2a-IFN) was conducted in 44 patients. Patients had not received chemotherapy previously and had measurable metastatic gastric carcinoma. 5-FU was administered as a continuous infusion at a do

Phase II clinical trial of 13-cis-retino

Phase II clinical trial of 13-cis-retinoic acid and interferon-α-2a in patients with advanced esophageal carcinoma

✍ Peter C. Enzinger; David H. Ilson; Leonard B. Saltz; Lisa K. Martin; David P. Ke 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

## BACKGROUND. Interferon in combination with 5-fluorouracil has been shown to be active in squamous cell carcinoma (SCC) and adenocarcinoma (AC) of the esophagus. 13-cis-retinoic acid (CRA) has chemopreventive activity in SCC of the head and neck, and, in combination with interferon, has antitumo